InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Pierce Robert Hamilton, Executive. Officer active across 1 company, notably Sensei Biotherapeutics, Inc.. In total, 3 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €139k. History available since 6 August 2021. The latest transaction was filed on 15 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Pierce Robert Hamilton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
21,000 shares0Common StockSEC:0001209191-22-010982:0
16,030 shares@ US$7.343672.1% of flowCommon StockSEC:0001209191-21-051172:0
6,460 shares@ US$7.112727.9% of flowCommon StockSEC:0001209191-21-050659:0
3 of 3 declarations
About Pierce Robert Hamilton
Robert Hamilton Pierce is the Chief Scientific Officer and Chief R&D Officer at Sensei Biotherapeutics, Inc. He is responsible for leading research and innovation efforts. Robert plays a key role in developing new therapies to address medical needs.
